Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
47 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014', provides an overview of the Orchid Chemicals & Pharmaceuticals Ltd's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Orchid Chemicals & Pharmaceuticals Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Orchid Chemicals & Pharmaceuticals Ltd including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Orchid Chemicals & Pharmaceuticals Ltd's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Orchid Chemicals & Pharmaceuticals Ltd's pipeline products Reasons to buy - Evaluate Orchid Chemicals & Pharmaceuticals Ltd's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Orchid Chemicals & Pharmaceuticals Ltd in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Orchid Chemicals & Pharmaceuticals Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Orchid Chemicals & Pharmaceuticals Ltd and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Orchid Chemicals & Pharmaceuticals Ltd - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Orchid Chemicals & Pharmaceuticals Ltd and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Orchid Chemicals & Pharmaceuticals Ltd Snapshot 6 Orchid Chemicals & Pharmaceuticals Ltd Overview 6 Key Information 6 Key Facts 6 Orchid Chemicals & Pharmaceuticals Ltd - Research and Development Overview 7 Key Therapeutic Areas 7 Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Partnered Products 12 Partnered Products/Combination Treatment Modalities 13 Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products Glance 14 Orchid Chemicals & Pharmaceuticals Ltd - Clinical Stage Pipeline Products 14 Phase I Products/Combination Treatment Modalities 14 Orchid Chemicals & Pharmaceuticals Ltd - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 Orchid Chemicals & Pharmaceuticals Ltd - Drug Profiles 17 OCID-4681 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 OCID-0050 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 OCID-2987 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 OCID-5005 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 OCID-5090 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Small Molecule to Inhibit Dipeptidyl-Peptidase IV for Type 2 Diabetes 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Small Molecule to Inhibit IL-6 and STAT3 for Oncology 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Small Molecule to Inhibit Th1/Th2 Cytokine Synthase for Inflammation 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Small Molecule to Inhibit TNF Alpha for Inflammation 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 tubastatin 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 cephalosporin 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Small Molecule 1 to Inhibit HDAC for Oncology 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 Small Molecule 2 to Inhibit HDAC for Oncology 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 Small Molecule 3 to Inhibit HDAC for Oncology 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 Small Molecule for Central Nervous System 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 Small Molecule for Diabetes 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Small Molecule for Obesity 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 Small Molecule to Antagonize ALK for Lung Cancer 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 Small Molecules for Tuberculosis 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Analysis 37 Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Target 37 Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Route of Administration 39 Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Molecule Type 40 Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Mechanism of Action 41 Orchid Chemicals & Pharmaceuticals Ltd - Dormant Projects 43 Orchid Chemicals & Pharmaceuticals Ltd - Locations And Subsidiaries 44 Head Office 44 Other Locations & Subsidiaries 44 Appendix 46 Methodology 46 Coverage 46 Secondary Research 46 Primary Research 46 Expert Panel Validation 46 Contact Us 47 Disclaimer 47
List of Tables Orchid Chemicals & Pharmaceuticals Ltd, Key Information 6 Orchid Chemicals & Pharmaceuticals Ltd, Key Facts 6 Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Indication, 2014 9 Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Stage of Development, 2014 10 Orchid Chemicals & Pharmaceuticals Ltd - Monotherapy Products in Pipeline, 2014 11 Orchid Chemicals & Pharmaceuticals Ltd - Partnered Products in Pipeline, 2014 12 Orchid Chemicals & Pharmaceuticals Ltd - Partnered Products/ Combination Treatment Modalities, 2014 13 Orchid Chemicals & Pharmaceuticals Ltd - Phase I, 2014 14 Orchid Chemicals & Pharmaceuticals Ltd - Preclinical, 2014 15 Orchid Chemicals & Pharmaceuticals Ltd - Discovery, 2014 16 Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Target, 2014 38 Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Route of Administration, 2014 39 Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Molecule Type, 2014 40 Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Mechanism of Action, 2014 42 Orchid Chemicals & Pharmaceuticals Ltd - Dormant Developmental Projects,2014 43 Orchid Chemicals & Pharmaceuticals Ltd, Other Locations 44 Orchid Chemicals & Pharmaceuticals Ltd, Subsidiaries 45
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
